The global T-Cell Therapy Market, valued at US$ 5.3 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 27.9% from 2023 to 2033, reaching US$ 76.6 billion by 2033. T-cell therapies, particularly CAR T-cell therapies, represent a transformative immunotherapy approach, using genetically modified T-cells to target cancer cells, especially in hematological malignancies...